- Filed
- Oct 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 24, 2025 | 77.35M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 77.29M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 77.07M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 78.48M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 76.66M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $6.66M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $0 |
| Capex | Q3 2025 · Sep 30, 2025 | $177.82M |
| Capex | Q3 2025 · Sep 30, 2024 | $148.03M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$169.98M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $90.49M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $280M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $42.87M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $32.84M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $27.57M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$429.51M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$281.01M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $570.98M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $586.36M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $895.73M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $881.84M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $916.01M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $945.3M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $2.47B |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.85B |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $4.47B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $4.07B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $2.13B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.02B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $4.04B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $4.66B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.94 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$13.55 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.16 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.87 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.94 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$13.55 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.17 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.87 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $265.84M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $796.06M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $272.32M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $812.45M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$150.28M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.04B |
| Net Income | Q3 2025 · Jun 30, 2025 | −$869.06M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$24.98M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$12.77M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$66.57M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$31.91M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$21.89M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $26.47M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $6.55M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $31.08M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $54.97M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $375.07M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $1.09B |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $355.08M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $1.04B |
| Revenue | Q3 2025 · Sep 30, 2025 | $697.26M |
| Revenue | Q3 2025 · Sep 30, 2025 | $2.05B |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $686.85M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $1.99B |